Izotropic Gains Visibility as AI Market Broadens Beyond Tech - Seite 2

These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.

Contacts:

Robert Thast, Interim Chief Executive Officer
Telephone: [phone] or 1-833-IZOCORP ext. 1
Email: [e-mail]

James Gagnon, International Communications
Telephone: [phone] or 1-833-IZOCORP ext. 2
Email: [e-mail]

General and Corporate Inquiries
Telephone: [phone] or 1-833-IZOCORP ext. 3
Email: [e-mail]

Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[e-mail]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265877

The Izotropic Corporation Stock at the time of publication of the news with a raise of +2,64 % to 0,195EUR on Tradegate stock exchange (09. September 2025, 22:26 Uhr).